True hermaphroditism with dysgerminoma: A case report

• Published in: Medicine (Baltimore) 2020-05, Vol.99 (22), p.e20472-e20472
• Main Authors: Chen, Chun-Qiao, Liu, Zheng, Lu, Yu-Song, Pan, Min, Huang, Hui
• Format: Article
• Language: English
• Subjects: Diagnosis, Differential; Dysgerminoma - complications; Dysgerminoma - diagnosis; Dysgerminoma - pathology; Dysgerminoma - therapy; Female; Humans; Male; Middle Aged; Ovarian Neoplasms - complications; Ovarian Neoplasms - diagnosis; Ovarian Neoplasms - pathology; Ovarian Neoplasms - therapy; Ovotesticular Disorders of Sex Development - complications; Ovotesticular Disorders of Sex Development - diagnosis; Ovotesticular Disorders of Sex Development - pathology; Ovotesticular Disorders of Sex Development - therapy
• ISSN: 0025-7974; 1536-5964
• DOI: 10.1097/MD.0000000000020472

True hermaphroditism is a rare and usually sporadic disorder. It is defined by the presence of both ovarian and testicular tissues together as ovotestis. In this study, we reported a rare true hermaphroditism case with dysgerminoma. A 49-year-old woman developed masses in both inguinal regions for 30 years. Recently 3 months, the patient found that the size of mass in her left inguinal region was significantly increased. After surgical resection, the results of immunohistochemical examination in left mass revealed a dysgerminoma with positive expression of placental alkaline phosphatase and octamer-binding transcription factor 3/4, and right mass was a cryptorchidism. Chromosomal analysis revealed the karyotype 46, XY. Combined immunohistochemical and karyotype analysis, a diagnosis of true hermaphroditism with dysgerminoma was made. Radiotherapy combined with chemotherapy after tumor resection was used to improve her prognosis. Hormone replacement therapy with conjugated estrogen and medroxyprogesterone acetate were used to maintain her female characteristics. The patient underwent hormonal replacement and has been well for 6 months. The positive expression of placental alkaline phosphatase and octamer-binding transcription factor 3/4 could be 2 diagnosis markers of dysgerminoma. Surgery combined with radiotherapy and chemotherapy could improve the prognosis of dysgerminoma. Moreover, hormone replacement therapy with conjugated estrogen and medroxyprogesterone acetate was very helpful to maintain the female characteristic of patients with true hermaphroditism.